US Irritable Bowel Syndrome Treatment Market to 2028 - Country Analysis and Forecasts by Type ; Product ; Distribution Channel
- Published Date: 2022-12-26
- Report ID: 138110
- Pages: 200
-
Format:
Report Overview
The US Irritable Bowel Disease (IBD) treatment market size stood at around USD 586.61 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period 2019-2028
Market Growth Drivers
The growth of the US irritable bowel syndrome treatment market is primarily attributed to the increasing prevalence of irritable bowel syndrome and associated conditions, and increasing numbers of FDA approvals and drug developments. However, the limitations with regard to product availability and treatment inefficiency are likely to continue to restrain the growth of market during the forecast years. The increasing number of FDA approvals and drug development activities is likely to accelerate the growth of the US irritable bowel syndrome treatment market during the forecast period
1. US Irritable Bowel Syndrome Treatment Market Overview......
A. Market Size
2. Market Growth Drivers.......
A. Increasing prevalence of irritable bowel syndrome and associated conditions
B. Increasing number of FDA approvals and drug developments
3. Irritable Bowel Syndrome Treatment Market Segmentation......
A. By Type
I. Mixed IBS (IBS-M)
II. IBS with Diarrhea (IBS-D)
III. IBS with Constipation (IBS-C)
B. By Product
I. Rifaximin
II. Eluxadoline
III. Lubiprostone
IV. Linaclotide
V. Others
C. By Distribution Channel
I. Hospital Pharmacies
II. Drug Stores and Retail Pharmacies
III. Online Pharmacies
4. Irritable Bowel Syndrome Major Market Share................
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape......
A. Major Players
B. Products in Pipeline
6. Key Company Profiles....
A. Allergan Company overview, Product & Services, Strategies & Financials
B. Takeda Company overview, Product & Services, Strategies & Financials
C. Astellas Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape...
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth.
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
I. Increasing disposable incomes of the population
B. Future Trends
I. Development of medical devices for the treatment of irritable bowel syndrome
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
